Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Tetrahydropalmatine may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Tetrahydropalmatine may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Tetrahydropalmatine. |
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Tetrahydropalmatine. |
| Amifostine | Tetrahydropalmatine may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Tetrahydropalmatine. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Obinutuzumab | Tetrahydropalmatine may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Tetrahydropalmatine. |
| Rituximab | Tetrahydropalmatine may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Isoetharine | Isoetharine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Norepinephrine | Norepinephrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Phenylpropanolamine | Phenylpropanolamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Metaraminol | Metaraminol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Methoxamine | Methoxamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Orciprenaline | Orciprenaline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Dobutamine | Dobutamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Ritodrine | Ritodrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Bitolterol | Bitolterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Dopamine | Dopamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Isoprenaline | Isoprenaline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Arbutamine | Arbutamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Fenoterol | Fenoterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Pirbuterol | Pirbuterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Ephedra sinica root | Ephedra sinica root may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Ephedrine | Ephedrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Procaterol | Procaterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Clenbuterol | Clenbuterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Bambuterol | Bambuterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Tetrahydropalmatine. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Amibegron | Amibegron may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Solabegron | Solabegron may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Droxidopa | Droxidopa may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Isometheptene | Isometheptene may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Levonordefrin | Levonordefrin may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Naphazoline | Naphazoline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Tetryzoline | Tetryzoline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Tyramine | Tyramine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Adrafinil | Adrafinil may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Hexoprenaline | Hexoprenaline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Etilefrine | Etilefrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Cirazoline | Cirazoline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Synephrine | Synephrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Moxisylyte | Moxisylyte may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Racepinephrine | Racepinephrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| DL-Methylephedrine | DL-Methylephedrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Amitraz | Amitraz may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Atipamezole | Atipamezole may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Ractopamine | Ractopamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Etafedrine | Etafedrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| PF-00610355 | PF-00610355 may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Abediterol | Abediterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Tulobuterol | Tulobuterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Idazoxan | Idazoxan may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Higenamine | Higenamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Reproterol | Reproterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Theodrenaline | Theodrenaline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Tramazoline | Tramazoline may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Octopamine | Octopamine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Fenozolone | Fenozolone may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Norfenefrine | Norfenefrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Oxyfedrine | Oxyfedrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Xenon | Xenon may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Buflomedil | Buflomedil may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Rimiterol | Rimiterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Tretoquinol | Tretoquinol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Prenalterol | Prenalterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Xamoterol | Xamoterol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Mefenorex | Mefenorex may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Deoxyepinephrine | Deoxyepinephrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Quinoline Yellow WS | Quinoline Yellow WS may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Isoxsuprine | Isoxsuprine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Moxonidine | Moxonidine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Methylergometrine | Methylergometrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Epinephrine | Epinephrine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Levosalbutamol | Levosalbutamol may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Dihydroergocristine | Dihydroergocristine may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Terguride | Terguride may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Acetylsalicylic acid | Acetylsalicylic acid may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Selpercatinib | Selpercatinib may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Naxitamab | Naxitamab may decrease the antihypertensive activities of Tetrahydropalmatine. |
| Buprenorphine | Tetrahydropalmatine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Tetrahydropalmatine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Tetrahydropalmatine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Tetrahydropalmatine. |
| Hydrocodone | Tetrahydropalmatine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Tetrahydropalmatine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Tetrahydropalmatine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Tetrahydropalmatine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Tetrahydropalmatine. |
| Mirtazapine | Tetrahydropalmatine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Tetrahydropalmatine. |